Successful use of human amniotic allograft membrane in the treatment of recalcitrant driveline infections

Driveline infections represent a significant source of morbidity and mortality in left ventricular assist device (LVAD) patients. Driveline infection occur in up to 40% of cases and have recurrence rates up to 50%. Current literature fails to demonstrate specific interventions capable of reducing pr...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Cristiano Spadaccio, MD, PhD, Udit Vyas, MD, MS, Antonio Panza, MD, Russell Samuel Vester, MD, Louis Benson Louis IV, MD
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-11-01
Saila:	JHLT Open
Gaiak:	Driveline infection Left ventricular assist device (LVAD) Human amniotic allograft membrane
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2950133425001466
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!